

Netmeds First Membership
Quick Links
Introduction About MASTERTAZ 500/62.5MG INJECTION
MASTERTAZ 500/62.5MG INJECTION is a combination of Ceftazidime and Tazobactam which belongs to the group of medicines called Antibiotics. It is indicated in the management of various infections such as joint and bone infections, gynaecological infections, infections in patients suffering from Febrile Neutropenia, meningitis, lung infections (Ex. pneumonia, pseudomonal lung infection in Cystic Fibrosis), bacterial infections of the skin, lower respiratory tract infections, urinary tract infections, intra-abdominal infections, septicaemia, ear infections, vibrio infections, and perioperative prophylaxis.
Prior to the management with MASTERTAZ 500/62.5MG INJECTION, your doctor might ask you to take certain diagnostic tests. MASTERTAZ 500/62.5MG INJECTION is not recommended for use in patients with liver disease, seizures, or infection due to a specific bacteria (C. difficile). In pregnant and breastfeeding women, MASTERTAZ 500/62.5MG INJECTION should be used with caution.
The most common side effects of receiving MASTERTAZ 500/62.5MG INJECTION are injection site inflammation, rashes, fever, diarrhoea, nausea, headache, dizziness, constipation, indigestion, and pain. Inform your doctor if any of these worsen or don’t improve.
Uses Of MASTERTAZ 500/62.5MG INJECTION
Manages,
- joint and bone infections
- gynaecological infections
- infections in patients suffering from febrile neutropenia
- meningitis
- lung infections (Ex. pneumonia, pseudomonal lung infection in Cystic Fibrosis)
- bacterial infections of the skin
- lower respiratory tract infections
- urinary tract infections
- intra-abdominal infections
- septicaemia
- ear infections
- vibrio infections
- perioperative prophylaxis
How MASTERTAZ 500/62.5MG INJECTION Works
MASTERTAZ 500/62.5MG INJECTION aids in the management of a variety of infections. Ceftazidime is a cephalosporin antibiotic that inhibits penicillin-binding proteins, which are essential for bacterial survival. This leads to the destruction of the bacterial cell wall and, hence, the bacteria. Tazobactam is a beta-lactamase inhibitor, which interacts with an enzyme called beta-lactamase and protects the efficiency of ceftazidime against bacteria.
How to use MASTERTAZ 500/62.5MG INJECTION
MASTERTAZ 500/62.5MG INJECTION will be given to you only by a doctor or a nurse into a vein or a muscle as an intravenous or intramuscular infusion. Your doctor will decide the correct dose and duration of MASTERTAZ 500/62.5MG INJECTION for you depending upon your age, body weight and disease condition.
Side Effects Of MASTERTAZ 500/62.5MG INJECTION
Common
- injection site inflammation
- rashes
- fever
- diarrhoea
- nausea
- headache
- dizziness
- constipation
- indigestion
- pain
How To Manage Side Effects
Constipation
Eat plenty of fiber rich foods such as vegetables, fresh fruits, and cereals and drink plenty of water while taking MASTERTAZ 500/62.5MG INJECTION. Exercise more regularly. If the symptom doesn’t improve, contact your doctor.
Diarrhea
Drink a lot of fluids, such as water, squash, or fruit juice to keep yourself hydrated. Do not consume any medicine by yourself with MASTERTAZ 500/62.5MG INJECTION without consulting your doctor. If the symptom doesn’t improve, contact your doctor.
Headache
Try to take a rest. Apply a pain-relieving balm on your forehead. If the symptom doesn’t improve, contact your doctor.
Nausea And Vomiting
While receiving MASTERTAZ 500/62.5MG INJECTION, stick to simple meals. Avoid eating rich or spicy food. If the symptom doesn’t improve, contact your doctor.
Warning & Precautions
Pregnancy
Use with CautionMASTERTAZ 500/62.5MG INJECTION should be used with caution in pregnant women. Consult your doctor before receiving MASTERTAZ 500/62.5MG INJECTION.
Breastfeeding
Use with CautionMASTERTAZ 500/62.5MG INJECTION should be used with caution in breastfeeding women. Consult your doctor before receiving MASTERTAZ 500/62.5MG INJECTION.
Liver
Use with CautionMASTERTAZ 500/62.5MG INJECTION should be used with caution in patients having liver disease. Consult your doctor before receiving it.
Allergy
ContraindicatedTell your doctor before receiving MASTERTAZ 500/62.5MG INJECTION if you are allergic to Ceftazidime and Tazobactam.
Use In Pediatrics
Consult your doctorYour doctor will decide the correct dose and duration of the management with MASTERTAZ 500/62.5MG INJECTION for your child depending upon your child’s age, diseases condition and body weight. Consult your doctor for advice.
Use In Geriatrics
Consult your doctorYour doctor will decide the correct dose and duration of the management with MASTERTAZ 500/62.5MG INJECTION for you depending upon your age, diseases condition and body weight. Consult your doctor for advice.
Others
MASTERTAZ 500/62.5MG INJECTION should not be given to patients having:
- seizures (fits)
- infection due to a specific bacteria (C difficile)
Interactions
A. Drug–Drug Interactions:
Before receiving MASTERTAZ 500/62.5MG INJECTION, inform your doctor if you are taking any of the following medicine:
- other cephalosporins such as cefadroxil, cefepime, ceftriaxone and other penicillins such as amoxicillin, nafcillin, and ampicillin (used to manage various infections)
Overdosage:
MASTERTAZ 500/62.5MG INJECTION will be administered to you only by a doctor or a nurse in a hospital, so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms.
Synopsis
| Drug | : | Ceftazidime, Tazobactam |
| Pharmacological Category | : | Cephalosporins, Beta-Lactamase Inhibitors |
| Therapeutic Indication | : | Various infections |
| Dosage Forms | : | Injection |
More Information
- Keep MASTERTAZ 500/62.5MG INJECTION out of reach from children
- Store at room temperature
FAQs About MASTERTAZ 500/62.5MG INJECTION
Q: What is MASTERTAZ 500/62.5MG INJECTION and why is it prescribed?
A: MASTERTAZ 500/62.5MG INJECTION is a combination of Ceftazidime and Tazobactam, which belongs to the group of medicines called antibiotics. It is used to manage a variety of infections, including joint and bone infections, gynaecological infections, infections in patients with febrile neutropenia, meningitis, lung infections (such as pneumonia and pseudomonal lung infection in Cystic Fibrosis), bacterial skin infections, lower respiratory tract infections, urinary tract infections, intra-abdominal infections, septicaemia, ear infections, vibrio infections, and perioperative prophylaxis.
Q: How is MASTERTAZ 500/62.5MG INJECTION administered?
A: MASTERTAZ 500/62.5MG INJECTION will be given to you only by a doctor or a nurse into a vein or a muscle as an intravenous or intramuscular infusion. Your doctor will determine the correct dose and duration of MASTERTAZ 500/62.5MG INJECTION for you depending on your age, body weight, and disease condition.
Q: Can MASTERTAZ 500/62.5MG INJECTION be administered to pregnant and breastfeeding women?
A: In pregnant and breastfeeding women, MASTERTAZ 500/62.5MG INJECTION should be used with caution. Consult your doctor before receiving MASTERTAZ 500/62.5MG INJECTION.
Q: Can MASTERTAZ 500/62.5MG INJECTION cause diarrhoea?
A: Diarrhoea is a common side effect of MASTERTAZ 500/62.5MG INJECTION. Drink a lot of fluids, such as water, squash, or fruit juice, to keep yourself hydrated. Do not take any medicine containing MASTERTAZ 500/62.5MG INJECTION without first consulting your doctor. If the symptom doesn’t improve, contact your doctor.
Q: Is MASTERTAZ 500/62.5MG INJECTION an antibiotic?
A: Yes. MASTERTAZ 500/62.5MG INJECTION is a combination of Ceftazidime and Tazobactam, which are antibiotics. They work by destroying the bacterial cell and managing further growth, effectively managing infections.
References
1. KD. Tripathi. Antimicrobial Drugs. Essentials of medical pharmacology. Seventh edition. 2013. Page – 725, 728.
2. NIH National Library of Medicine, National center for biotechnology information. Pubchem. Ceftazidime. [Accessed on 15th July 2022] https://pubchem.ncbi.nlm.nih.gov/compound/Ceftazidime
3. NIH National Library of Medicine, National center for biotechnology information. Pubchem. Tazobactam. [Accessed on 15th July 2022] https://pubchem.ncbi.nlm.nih.gov/compound/Tazobactam
4. Bionova Lifesciences. Ceftadis-TB. [Accessed on 15th July 2022] https://www.bionova.co.in/ceftadis-tb-injection.html
5. Mits Healthcare Mietrex – TM. [Accessed on 15th July 2022] https://www.mitshealthcare.in/product/ceftriaxone-tazobactam-injection-manufacturers-suppliers-2
6. MIMS. Cazotaz. [Accessed on 15th July 2022] https://www.mims.com/india/drug/info/cazotaz
Useful Diagnostic Tests
- Complete Blood Count
- Urine Analysis
- Xray

